Drugs that contain Triptorelin Pamoate
1. Trelstar patents expiration
TRELSTAR's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5776885 | VERITY | Sustained and controlled release of water insoluble polypeptides |
Jul, 2015
(8 years ago) | |
| US10166181 | VERITY | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(5 years from now) | |
Market Authorisation Date: 15 June, 2000
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR
More Information on Dosage
TRELSTAR family patents
2. Triptodur Kit patents expiration
TRIPTODUR KIT's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10166181 | AZURITY | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(5 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-149) | Jun 29, 2024 |
| Orphan Drug Exclusivity(ODE) | Jun 29, 2024 |
| New Product(NP) | Jun 29, 2020 |
Market Authorisation Date: 29 June, 2017
Treatment: NA
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
More Information on Dosage
TRIPTODUR KIT family patents